Kevin Koch
Venture Partner @ OrbiMed
Boulder, United States
Kevin Koch is a Series A investor at OrbiMed in Boulder. Kevin Koch is based out of Boulder, Colorado and is the President and CEO of Edgewise Therapeutics. Kevin previously worked at Biogen as a Senior Vice President, Drug Discovery, Chemical & Molecular Therapeutics. Kevin Koch attended State University of New York, Stony Brook.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Stages Kevin Koch invests in
Countries Kevin Koch invests in
Investment Focus
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Terremoto Biosciences
|
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $108M / Series C / Apr 15, 2026 | |
|
Terremoto Biosciences
|
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $175M / Series B / Nov 02, 2023 | |
|
Terremoto Biosciences
|
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $75M / Series A / May 25, 2022 |
Co-Investors
About OrbiMed
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investmentsseries of venture capital funds and a family of public equity investment funds.
OrbiMed Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dina Chaya
Partner
|
|||
|
Kevin Koch
Venture Partner
|
|||
Rishi Gupta
Private Equity Partner
|
|||
Sunny Sharma
Senior Managing Director
|
|||
Tadd S. Wessel
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
FAQ
When did Kevin Koch last invest?
The most recent investment recorded for Kevin Koch closed in Apr 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
